Bill Aims to Push China Out of Pharmaceutical Supply Chain
Sen. Tom Cotton, R-Ark., and Rep. Mike Gallagher, R-Wis., said they will introduce a bill that aims to push China out of the pharmaceutical supply chain, though it would not take effect until 2022. It would bar the Veterans Administration,…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
the Pentagon and the Department of Health and Human Services from buying drugs that are either manufactured in China or have their active pharmaceutical ingredients made in China. If it becomes law, it would also require drug companies to list the APIs and their countries of origin on the labels of drugs, whether imported or domestic. “This is a national security imperative that to many Americans, is a matter of life and death,” Gallagher said. “It's past time for us to develop an aggressive plan to move critical pharmaceutical supply chains away from China.”